Market Research Logo

ENT Disorder Treatment Market, by Treatment Type, Organ Type, End User, and Region - Global Trends, and Forecast to 2025

ENT Disorder Treatment Market, by Treatment Type, Organ Type, End User, and Region - Global Trends, and Forecast to 2025

Factors such as sinusitis and aging, affects normal functioning of ear, nose and throat. ENT is one of the most important branches of medical science, also known as otolaryngology, which is focused on diagnosis and treatment of disorders associated with ear, nose, and throat. Dysfunction of these organs may affect the person’s quality of life. Disorders related to ENT are treated with the help of devices as well as various classes of drugs. The report mainly covers drug classes and medical devices used for the treatment of disease such as sinusitis, rhinitis, otitis media, tonsillitis, and others.
Market Dynamics
Major factor contributing to growth of the global ENT disorder treatment market includes increasing pollution. For instance, according to the World Health Organization 2015, over 4 million children die each year, globally due to environmental causes such as pollution and pollen grain infections. Several other factors contributing to the market growth includes, increasing R&D for drugs for treatment of ENT, and rising geriatric population and others. Rising awareness about the ENT treatments in emerging economies would increase the opportunities for market players to invest and capitalize in such regions. Asia Pacific is expected to witness significant traction in the global ENT disorder treatment market over the forecast period. This is owing to focus of key players on geographical expansion in the region and increasing R&D in ENT by various educational and research institutes in collaboration with local players. However, low awareness about the availability of treatments in some emerging economies such as several African countries as well as threat of developing antibiotic resistance are factors that are expected to hinder the market growth.
Key features of the study:

This report provides in-depth analysis of global ENT disorder treatment market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2016 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global ENT disorder treatment market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study Sanofi, AstraZeneca, Novartis AG, Pfizer Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline Pharmaceuticals, Otonomy Inc., Merck & Co., Dr. Reddy’s Laboratories Ltd., Allergan plc, Cochlear Ltd., Sonova Holding AG, Siemens Healthcare, Starkey Laboratories Inc., William Demant Holding A/S, Widex A/S, GN ReSound A/S, Sonic Innovations Inc., Panasonic Corp., Beltone, Rexton Inc., Avada Hearing Care, Miracle-Ear Inc., MED-EL GmbH, Nuear Hearing Aids Inc., Audiosync Inc., Bernafon, American Hearing Systems Inc., Unitron Hearing Inc., and Zounds Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global ENT disorder treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the ENT disorder treatment market

Detailed Segmentation:

Global ENT Disorder Treatment Market, By Treatment Type:

By Devices

Hearing Aid Devices
Voice Prostheses
Nasal Splints
Hearing Implants
Others

By Drugs

Antibiotics
Antihistamines
Steroids
Anti-inflammatory Drugs
Others          

Global ENT Disorder Treatment Market, By Organ Type:

Ears
Nose
Throat

Global ENT Disorder Treatment Market, By End User:

Hospitals
Clinics
Ambulatory Surgical Centers
Home Care Settings
Others

Global ENT Disorder Treatment Market, By Geography:

North America

By Treatment Type:

By Devices

Hearing Aid Devices
Voice Prostheses
Nasal Splints
Hearing Implants
Others

By Drugs

Antibiotics
Antihistamines
Steroids
Anti-inflammatory Drugs
Others

By Organ Type:

Ears
Nose
Throat

By End User:

Hospitals
Clinics
Ambulatory Surgical Centers
Home Care Settings
Others

By Country:

U.S.
Canada

Latin America

By Treatment Type:

By Devices

Hearing Aid Devices
Voice Prostheses
Nasal Splints
Hearing Implants
Others

By Drugs

Antibiotics
Antihistamines
Steroids
Anti-inflammatory Drugs
Others

By Organ Type:

Ears
Nose
Throat

By End User:

Hospitals
Clinics
Ambulatory Surgical Centers
Home Care Settings
Others

By Country:

Brazil
Mexico
Argentina
Rest of Latin America

Europe

By Treatment Type:

By Devices

Hearing Aid Devices
Voice Prostheses
Nasal Splints
Hearing Implants
Others

By Drugs

Antibiotics
Antihistamines
Steroids
Anti-inflammatory Drugs
Others

By Organ Type:

Ears
Nose
Throat

By End User:

Hospitals
Clinics
Ambulatory Surgical Centers
Home Care Settings
Others

By Country:

Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe

Asia Pacific

By Treatment Type:

By Devices

Hearing Aid Devices
Voice Prostheses
Nasal Splints
Hearing Implants
Others

By Drugs

Antibiotics
Antihistamines
Steroids
Anti-inflammatory Drugs
Others

By Organ Type:

Ears
Nose
Throat

By End User:

Hospitals
Clinics
Ambulatory Surgical Centers
Home Care Settings
Others

By Country:

China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific

Middle East

By Treatment Type:

By Devices

Hearing Aid Devices
Voice Prostheses
Nasal Splints
Hearing Implants
Others

By Drugs

Antibiotics
Antihistamines
Steroids
Anti-inflammatory Drugs
Others

By Organ Type:

Ears
Nose
Throat

By End User:

Hospitals
Clinics
Ambulatory Surgical Centers
Home Care Settings
Others

By Country:

GCC
Israel
Rest of Middle East

Africa

By Treatment Type:

By Devices

Hearing Aid Devices
Voice Prostheses
Nasal Splints
Hearing Implants
Others

By Drugs

Antibiotics
Antihistamines
Steroids
Anti-inflammatory Drugs
Others

By Organ Type:

Ears
Nose
Throat

By End User:

Hospitals
Clinics
Ambulatory Surgical Centers
Home Care Settings
Others

By Country:

South Africa
Central Africa
North Africa

Company Profiles

Sanofi *

Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments

AstraZeneca Plc
Novartis AG
Pfizer, Inc.
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
GlaxoSmithKline Plc
Otonomy, Inc.
Merck & Co., Inc.
Reddy’s Laboratories Ltd.
Allergen Plc
Cochlear, Ltd.
Sonova Holdings AG
Siemens Healthineers
Starkey Laboratories, Inc.
William Demant Holdings A/S
Widex A/S
GN ReSound A/S
Sonic Innovations, Inc.
Panasonic Corporation
Beltone
Rexton, Inc.
Avada Hearing Care
Miracle-Ear, Inc.
MED-EL GmbH
Nuear Hearing Aids Inc.
AudioSync, Inc.
Bernafon
American Hearing Systems, Inc.
Unitron Hearing, Inc.
Zounds, Inc.

“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Treatment Type
Market Snippet, By Organ Type
Market Snippet, By End User
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Key Highlights
Reimbursement Scenario
Technological Advancements
Recent FDA Approvals
Regulatory Scenario
PEST Analysis
Epidemiology
4. Global ENT Disorder Treatment Market, By Treatment Type, 2017–2025, (US$ Million)
Introduction
Market Share Analysis, 2016 and 2025 (%)
Y-o-Y Growth Analysis, 2017–2025
Segment Trends
By Devices
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Million)
Segment Trends
Hearing Aid Devices
Voice Prostheses
Nasal Splints
Hearing Implants
Others
By Drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Million)
Segment Trends
Antibiotics
Antihistamines
Steroids
Anti-inflammatory Drugs
Others
5. Global ENT Disorder Treatment Market, By Organ Type, 2017–2025, (US$ Million)
Introduction
Market Share Analysis, 2016 and 2025 (%)
Y-o-Y Growth Analysis, 2017–2025
Segment Trends
Ears
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Million)
Nose
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Million)
Throat
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Million)
6. Global ENT Disorder Treatment Market, By End User, 2017–2025, (US$ Million)
Introduction
Market Share Analysis, 2016 and 2025 (%)
Y-o-Y Growth Analysis, 2017–2025
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Million)
Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Million)
Ambulatory Surgical Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Million)
Home Care Settings
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Million)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Million)
7. Global ENT Disorder Treatment Market, By Region, 2017–2025, (US$ Million)
Introduction
Market Share Analysis, By Region, 2016 and 2025 (%)
Y-o-Y Growth Analysis, For Regions, 2017–2025
North America
Market Size and Forecast, By Treatment Type, 2017–2025, (US$ Million)
Market Size and Forecast, By Organ Type, 2017–2025, (US$ Million)
Market Size and Forecast, By End User, 2017–2025, (US$ Million)
Market Size and Forecast, By Country, 2017–2025, (US$ Million)
U.S.
Canada
Latin America
Market Size and Forecast, By Treatment Type, 2017–2025, (US$ Million)
Market Size and Forecast, By Organ Type, 2017–2025, (US$ Million)
Market Size and Forecast, By End User, 2017–2025, (US$ Million)
Market Size and Forecast, By Country, 2017–2025, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Market Size and Forecast, By Treatment Type, 2017–2025, (US$ Million)
Market Size and Forecast, By Organ Type, 2017–2025, (US$ Million)
Market Size and Forecast, By End User, 2017–2025, (US$ Million)
Market Size and Forecast, By Country, 2017–2025, (US$ Million)
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Treatment Type, 2017–2025, (US$ Million)
Market Size and Forecast, By Organ Type, 2017–2025, (US$ Million)
Market Size and Forecast, By End User, 2017–2025, (US$ Million)
Market Size and Forecast, By Country, 2017–2025, (US$ Million)
China
India
Japan
Australia
South Korea
ASEAN
Rest of APAC
Middle East
Market Size and Forecast, By Treatment Type, 2017–2025, (US$ Million)
Market Size and Forecast, By Organ Type, 2017–2025, (US$ Million)
Market Size and Forecast, By End User, 2017–2025, (US$ Million)
Market Size and Forecast, By Country, 2017–2025, (US$ Million)
GCC
Israel
Rest of Middle East
Africa
Market Size and Forecast, By Treatment Type, 2017–2025, (US$ Million)
Market Size and Forecast, By Organ Type, 2017–2025, (US$ Million)
Market Size and Forecast, By End User, 2017–2025, (US$ Million)
Market Size and Forecast, By Country, 2017–2025, (US$ Million)
South Africa
Central Africa
North Africa
8. Competitive Landscape
Heat Map Analysis
Market Share Analysis
Company Profiles
Sanofi*
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
AstraZeneca Plc
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Novartis AG
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Pfizer, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Mylan N.V.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Teva Pharmceutical Industries Ltd.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
GlaxoSmithKline Plc
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Otonomy, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Merck & Co., Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Dr. Reddy’s Laboratories Ltd.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Allergen Plc
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Cochlear Ltd.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Sonova Holdings AG.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Siemens Healthineers
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Starkey Laboratories, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
William Demant Holdings, A/S
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Widex A/S
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
GN Re/Sound A/S
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Sonic Innovations. Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Panasonic Corporation
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Beltone
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Avada Hearing Care
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Miracle-Ear., Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
MED-EL GmBH
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Nuear Hearing Aids, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
AudioSync, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Bernafon
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
American Hearing Systems, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Unitron Hearing, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Zounds, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Analyst Views
9. Section
References
Research Methodology
About us and Sales Contact
*Browse 42 market data tables and 36 figures on "ENT Disorder Treatment Market - Global forecast to 2025”.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report